Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CRISTINA IVAN and GEORGE A CALIN.
CRISTINA IVAN
Connection Strength
5.372
GEORGE A CALIN
  1. Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. J Clin Invest. 2023 07 17; 133(14).
    View in: PubMed
    Score: 0.226
  2. 17?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer. Proc Natl Acad Sci U S A. 2023 06 06; 120(23):e2122053120.
    View in: PubMed
    Score: 0.224
  3. A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs. Front Cell Dev Biol. 2020; 8:50.
    View in: PubMed
    Score: 0.179
  4. OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018 08 30; 8(1):13106.
    View in: PubMed
    Score: 0.161
  5. Profiling the circulating miRnome reveals a temporal regulation of the bone injury response. Theranostics. 2018; 8(14):3902-3917.
    View in: PubMed
    Score: 0.159
  6. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447.
    View in: PubMed
    Score: 0.157
  7. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res. 2017 06 01; 23(11):2891-2904.
    View in: PubMed
    Score: 0.143
  8. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer. EBioMedicine. 2016 Nov; 13:113-124.
    View in: PubMed
    Score: 0.142
  9. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clin Cancer Res. 2017 Mar 01; 23(5):1323-1333.
    View in: PubMed
    Score: 0.141
  10. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine. 2015 Jun; 2(6):572-82.
    View in: PubMed
    Score: 0.128
  11. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014 Dec 04; 5:e1559.
    View in: PubMed
    Score: 0.125
  12. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells Mol Dis. 2014 Jun-Aug; 53(1-2):47-55.
    View in: PubMed
    Score: 0.118
  13. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013 Oct; 4(10):1748-62.
    View in: PubMed
    Score: 0.115
  14. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013 Nov; 3(11):1302-15.
    View in: PubMed
    Score: 0.114
  15. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12; 122(11):1891-9.
    View in: PubMed
    Score: 0.113
  16. microRNAs in cancer: from bench to bedside. Adv Cancer Res. 2010; 108:113-57.
    View in: PubMed
    Score: 0.089
  17. Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2024 Dec 04; 111:105486.
    View in: PubMed
    Score: 0.062
  18. The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia. Blood Cancer J. 2024 10 23; 14(1):168.
    View in: PubMed
    Score: 0.062
  19. Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov. 2023 Nov 08; 9(1):111.
    View in: PubMed
    Score: 0.058
  20. Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2023 Oct 31; 14:908-909.
    View in: PubMed
    Score: 0.058
  21. The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs. Cell Death Dis. 2023 05 22; 14(5):337.
    View in: PubMed
    Score: 0.056
  22. Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer. Ann Gastroenterol Surg. 2023 May; 7(3):458-470.
    View in: PubMed
    Score: 0.054
  23. Contributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers (Basel). 2022 Aug 30; 14(17).
    View in: PubMed
    Score: 0.053
  24. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. J Clin Invest. 2022 06 01; 132(11).
    View in: PubMed
    Score: 0.052
  25. lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer. Cancers (Basel). 2022 May 11; 14(10).
    View in: PubMed
    Score: 0.052
  26. Transcribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer. Biomolecules. 2022 01 26; 12(2).
    View in: PubMed
    Score: 0.051
  27. Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome. Mol Ther Nucleic Acids. 2022 Mar 08; 27:621-644.
    View in: PubMed
    Score: 0.051
  28. CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2022 Jan; 89:110147.
    View in: PubMed
    Score: 0.050
  29. ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer. Mol Ther Nucleic Acids. 2021 Mar 05; 23:930-943.
    View in: PubMed
    Score: 0.048
  30. Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 Oct 08; 11(1):5144.
    View in: PubMed
    Score: 0.047
  31. Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 09 24; 11(1):4840.
    View in: PubMed
    Score: 0.047
  32. FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs. Noncoding RNA. 2020 Sep 23; 6(4).
    View in: PubMed
    Score: 0.047
  33. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020 12; 159(6):2146-2162.e33.
    View in: PubMed
    Score: 0.046
  34. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2020 06 03; 11(1):2867.
    View in: PubMed
    Score: 0.046
  35. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. J Natl Cancer Inst. 2020 03 01; 112(3):266-277.
    View in: PubMed
    Score: 0.045
  36. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020 02; 578(7795):449-454.
    View in: PubMed
    Score: 0.045
  37. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020 10; 69(10):1818-1831.
    View in: PubMed
    Score: 0.045
  38. Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]. EBioMedicine. 2020 Feb; 52:102630.
    View in: PubMed
    Score: 0.044
  39. The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity. Cancers (Basel). 2020 Jan 17; 12(1).
    View in: PubMed
    Score: 0.044
  40. miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2. JCI Insight. 2020 01 16; 5(1).
    View in: PubMed
    Score: 0.044
  41. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020 04; 68:109539.
    View in: PubMed
    Score: 0.044
  42. The non-coding RNome after splenectomy. J Cell Mol Med. 2019 11; 23(11):7844-7858.
    View in: PubMed
    Score: 0.043
  43. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019 02 01; 21(1):20.
    View in: PubMed
    Score: 0.042
  44. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer. 2019 02; 120(3):340-345.
    View in: PubMed
    Score: 0.041
  45. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018 Dec; 38:100-112.
    View in: PubMed
    Score: 0.041
  46. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clin Cancer Res. 2018 09 01; 24(17):4225-4241.
    View in: PubMed
    Score: 0.040
  47. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion. Cancer Lett. 2018 08 28; 430:47-56.
    View in: PubMed
    Score: 0.039
  48. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun. 2018 01 31; 9(1):461.
    View in: PubMed
    Score: 0.039
  49. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018 01 08; 9(1):160.
    View in: PubMed
    Score: 0.039
  50. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2017 11 27; 8(1):1801.
    View in: PubMed
    Score: 0.038
  51. TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun. 2017 10 16; 8(1):947.
    View in: PubMed
    Score: 0.038
  52. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. J Neurooncol. 2018 Jan; 136(1):33-39.
    View in: PubMed
    Score: 0.038
  53. Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov. 2017; 3:17029.
    View in: PubMed
    Score: 0.038
  54. Ultraconserved long non-coding RNA uc.63 in breast cancer. Oncotarget. 2017 May 30; 8(22):35669-35680.
    View in: PubMed
    Score: 0.037
  55. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 05 24; 18(1):98.
    View in: PubMed
    Score: 0.037
  56. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017 Sep 01; 23(17):5255-5266.
    View in: PubMed
    Score: 0.037
  57. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine. 2017 Jun; 20:182-192.
    View in: PubMed
    Score: 0.037
  58. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs. Oncotarget. 2017 Mar 21; 8(12):20145-20164.
    View in: PubMed
    Score: 0.037
  59. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2017 Feb 14; 8(7):11641-11658.
    View in: PubMed
    Score: 0.036
  60. MALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 2017 01 11; 17(1):46.
    View in: PubMed
    Score: 0.036
  61. Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. Cancer Res. 2016 12 15; 76(24):7194-7207.
    View in: PubMed
    Score: 0.035
  62. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8).
    View in: PubMed
    Score: 0.034
  63. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104.
    View in: PubMed
    Score: 0.034
  64. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):640.
    View in: PubMed
    Score: 0.034
  65. Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene. 2016 09 15; 35(37):4914-26.
    View in: PubMed
    Score: 0.034
  66. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.034
  67. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. 2016 08 18; 35(33):4312-20.
    View in: PubMed
    Score: 0.034
  68. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48.
    View in: PubMed
    Score: 0.033
  69. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Rep. 2015 Dec 22; 13(11):2395-2402.
    View in: PubMed
    Score: 0.033
  70. PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst. 2016 Jan; 108(1).
    View in: PubMed
    Score: 0.033
  71. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205.
    View in: PubMed
    Score: 0.033
  72. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015 Jun 17; 6:7351.
    View in: PubMed
    Score: 0.032
  73. VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. Mol Cancer Res. 2015 Sep; 13(9):1274-82.
    View in: PubMed
    Score: 0.032
  74. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.032
  75. Low spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 2015 May 10; 6(13):11191-202.
    View in: PubMed
    Score: 0.032
  76. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget. 2015 Mar 30; 6(9):7262-79.
    View in: PubMed
    Score: 0.032
  77. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2016 06; 65(6):977-989.
    View in: PubMed
    Score: 0.032
  78. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol. 2015 Mar; 17(3):311-21.
    View in: PubMed
    Score: 0.032
  79. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res. 2015 May 01; 21(9):2127-37.
    View in: PubMed
    Score: 0.031
  80. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2014 Oct 29; 5:5202.
    View in: PubMed
    Score: 0.031
  81. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014 Nov 10; 26(5):707-21.
    View in: PubMed
    Score: 0.031
  82. Clinically relevant microRNAs in ovarian cancer. Mol Cancer Res. 2015 Mar; 13(3):393-401.
    View in: PubMed
    Score: 0.031
  83. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014 Sep 30; 5(18):8492-502.
    View in: PubMed
    Score: 0.031
  84. Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget. 2014 Mar 15; 5(5):1185-97.
    View in: PubMed
    Score: 0.030
  85. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer. 2014 Mar 18; 110(6):1614-21.
    View in: PubMed
    Score: 0.029
  86. HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal. 2014 Sep 10; 21(8):1220-38.
    View in: PubMed
    Score: 0.029
  87. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014 Feb; 8(1):83-92.
    View in: PubMed
    Score: 0.029
  88. targetHub: a programmable interface for miRNA-gene interactions. Bioinformatics. 2013 Oct 15; 29(20):2657-8.
    View in: PubMed
    Score: 0.029
  89. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61.
    View in: PubMed
    Score: 0.028
  90. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-a in breast cancer. Cancer Res. 2013 May 01; 73(9):2884-96.
    View in: PubMed
    Score: 0.027
  91. Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.
    View in: PubMed
    Score: 0.027
  92. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology. 2012 Apr; 142(4):886-896.e9.
    View in: PubMed
    Score: 0.025
  93. Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res. 2011 Dec 01; 17(23):7283-93.
    View in: PubMed
    Score: 0.025
  94. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4394-9.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.